 jKPGgkxbNb
Leonard chance1j@aol.com |
jKPGgkxbNb
Coolman delmar6x@lycos.com |
XXJDMnnYpR
Fidel arthurn82@gmail.com |
XXJDMnnYpR
Edmundo calebv61@aol.com |
XXJDMnnYpR
Royal stuart8w@yahoo.com |
XXJDMnnYpR
Wilson leigh1a@lycos.com |
XXJDMnnYpR
I came here to study http://www.thehomeshine.com youtube videos
Francois Venter of the University of the Witwatersrand, who is the lead clinical researcher for the South African leg of the trial, says that countries such as relatively wealthy South Africa may be able to provide TDF, which has been recommended for first-line treatment in the country since 2010. But "in a country like Malawi, let's say they use TDF for a year and then don't have the money and the alternative is d4T [at 30mg] and we do not have the data for the 20mg dosage, the reality is that, in many countries, if this study fails or shuts down, people are going to [continue to] be on 30mg d4T, rather than a safer dose of d4T".혻 |
Cletus chong2e@gmail.com |
fBeyFIcFDZZayE
Hassan jospeh0u@usa.net |
fBeyFIcFDZZayE
Savannah deadman@gmail.com |
fBeyFIcFDZZayE
Danny oscar9c@aol.com |
 [1] [2] [3] [4] [5] [6]  |
홈 
